Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Unilever confirms interest in GSK assets* GSK consumer business would be "strong strategic fit"* Sunday Times says 50 billion-pound bid rejected in late 2021* Unilever is under pressure from shareholders over stock price (Adds Unilever comment, ...
Read more* Unilever confirms interest in GSK assets* GSK consumer business would be "strong strategic fit"* Sunday Times says 50 billion-pound bid rejected in late 2021* Unilever is under pressure from shareholders over stock price (Adds background)By Mrin...
Read more(Updates with Unilever statement)LONDON, Jan 15 (Reuters) - Consumer goods giant Unilever said it had approached Glaxosmithkline about buying the pharmaceutical group's consumer goods arm after a newspaper reported that a 50 billion pound ($68.4 b...
Read moreLONDON, Jan 15 (Reuters) - Consumer goods giant Unilever has made a bid for pharmaceutical group Glaxosmithkline's consumer goods business worth roughly 50 billion pounds ($68.4 billion), Britain's Sunday Times reported.GSK and Pfizer, which owns...
Read more
World Health Organization approves two new Covid-19 treatments
Read moreGSK applies for tweaking of Covid-19 drug sotrovimab's use in US
Read moreTOP NEWS: GSK to sell 600,000 doses of Covid antibody treatment to US
Read morePARIS, Jan 7 (Reuters) - French health regulator HAS said on Friday that GSK's Xevudy treatment was promising against COVID-19 variants such as Omicron as it gave the treatment early access.HAS said in a statement the drug featured a mechanism whi...
Read moreDUBLIN, Jan 5 (Reuters) - Ireland's government agreed on Wednesday to fund the purchase of COVID-19 antiviral drugs from GlaxoSmithKline, Pfizer and Merck.Ireland plans to purchase the drugs through the European Union's procurement process and by ...
Read morePARIS, Jan 4 (Reuters) - Shares in biotech company Valneva were suspended briefly on the Paris stock market on Tuesday after dropping sharply.Valneva's share price has fluctuated in the past few weeks on news about the company's COVID-19 vaccine c...
Read moreLONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK
Read more
(Sharecast News) - Pharmaceutical giant GlaxoSmithKline said on Tuesday that ViiV Healthcare, its majority-owned subsidiary, had received approval from the Food and Drug Administration for Apretude, a long-acting injectable pre-exposure prophylaxis option that reduces the risk of sexually acquired HIV-1.
Read moreIN BRIEF: GSK's ViiV Healthcare gets US approval for Apretude
Read moreTOP NEWS: GSK appoints former Tesco CEO as consumer spin-off's chair
Read more
Last checked at